Literature DB >> 15034579

A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome.

Gevork N Mnatzakanian1, Hannes Lohi, Iulia Munteanu, Simon E Alfred, Takahiro Yamada, Patrick J M MacLeod, Julie R Jones, Stephen W Scherer, N Carolyn Schanen, Michael J Friez, John B Vincent, Berge A Minassian.   

Abstract

Rett syndrome is caused by mutations in the gene MECP2 in approximately 80% of affected individuals. We describe a previously unknown MeCP2 isoform. Mutations unique to this isoform and the absence, until now, of identified mutations specific to the previously recognized protein indicate an important role for the newly discovered molecule in the pathogenesis of Rett syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15034579     DOI: 10.1038/ng1327

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  107 in total

Review 1.  Complexities of Rett syndrome and MeCP2.

Authors:  Rodney C Samaco; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

3.  MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation.

Authors:  Malaika K Singleton; Michael L Gonzales; Karen N Leung; Dag H Yasui; Diane I Schroeder; Keith Dunaway; Janine M LaSalle
Journal:  Neurobiol Dis       Date:  2011-03-21       Impact factor: 5.996

4.  IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPARγ gene in male and female rat lungs during alveolarization.

Authors:  Lisa A Joss-Moore; Yan Wang; Elizabeth M Ogata; Anthony J Sainz; Xing Yu; Christopher W Callaway; Robert A McKnight; Kurt H Albertine; Robert H Lane
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-03-21

5.  Lost in translation: translational interference from a recurrent mutation in exon 1 of MECP2.

Authors:  A Saxena; D de Lagarde; H Leonard; S L Williamson; V Vasudevan; J Christodoulou; E Thompson; P MacLeod; D Ravine
Journal:  J Med Genet       Date:  2005-09-09       Impact factor: 6.318

6.  Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin.

Authors:  Tatiana Nikitina; Xi Shi; Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Jeffrey C Hansen; Christopher L Woodcock
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

Review 7.  Epigenetics, autism spectrum, and neurodevelopmental disorders.

Authors:  Sampathkumar Rangasamy; Santosh R D'Mello; Vinodh Narayanan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

8.  Methyl-CpG-Binding Protein 2 (MECP2) Polymorphism in Iranian Patients with Systemic Lupus Erythematosus.

Authors:  Samira Alesaeidi; Jafar Karami; Mahdi Mahmoudi; Mahmoud Akbarian; Shiva Poursani; Azadeh Amirzadeh; Nazgol-Sadat Haddadi; Elahe Saffari; Ahmad Reza Jamshidi
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

9.  Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia.

Authors:  J C Russell; M E Blue; M V Johnston; S Naidu; M A Hossain
Journal:  Neuroscience       Date:  2007-10-11       Impact factor: 3.590

Review 10.  Recent advances in MeCP2 structure and function.

Authors:  Kristopher C Hite; Valerie H Adams; Jeffrey C Hansen
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.